Electromedical Technologies (EMED) Stock Price

Electromedical Technologies Price

OTC·CLOSED
0.00
​
Market closed

Revenue at Electromedical Technologies has contracted by 26.0% per year over the past 10 years to 41,195.00 USD. For Electromedical Technologies, the net margin of -3,495.3% is down versus -934.6% a few years ago.

Electromedical Technologies stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Electromedical Technologies business model & stock analysis

Electromedical Technologies, Inc. generates revenue through the sale of medical devices for pain management, specifically targeting consumers and healthcare professionals. The company's primary products include WellnessPro Plus, WellnessPro POD, and Wellness ION Pen, which utilize bioelectronics and electrical impulses to alleviate pain without drugs. WellnessPro Plus functions as a prescription device that mimics the body's electric signals with micro-current stimulation, while the Wellness ION Pen delivers targeted frequency stimulation via interferential cold laser technology. These products are designed for both consumer and professional use in chronic and acute pain relief. The company focuses on developing electronic medicine solutions that combine micro-stimulation with expanded wavelength capabilities, particularly through the Wellness ION Pen, which is intended for over-the-counter sales. WellnessPro POD is part of the product lineup but lacks detailed description in the business description. The target segments are consumers seeking non-drug pain relief and healthcare professionals who prescribe or recommend these devices for pain management. Electromedical Technologies, Inc. markets its products under the WellnessPro and Wellness ION Pen brand names, emphasizing their unique bioelectronics approach. The company's revenue streams are derived from direct sales of these devices, with WellnessPro Plus positioned as an intelligent therapy device for both home and clinical use. The Wellness ION Pen's over-the-counter availability expands its market reach to general consumers who prefer non-prescription pain management solutions.

Frequently asked questions about Electromedical Technologies

Converted at the current exchange rate, the Electromedical Technologies share trades at 0.00 EUR (0.00 USD).

The revenue cannot currently be calculated for Electromedical Technologies.

The profit cannot currently be calculated for Electromedical Technologies.

The P/E ratio cannot be calculated for Electromedical Technologies at the moment.

The P/S cannot be calculated for Electromedical Technologies currently.

The Eulerpool Quality Score for Electromedical Technologies is 5/10.

The ISIN of Electromedical Technologies is US28540Q1004. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Electromedical Technologies is EMED. The ticker symbol is used to trade Electromedical Technologies shares on the stock exchange.

Fair ValueTerminal
0.00 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue per Employee
5,149.38 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Jun 17, 2019
ISIN
US28540Q1004
Cusip
28540Q100
Market capitalization
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
—
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
60.57 %
Last updated Nov 3, 2026, 10:49 AM

Electromedical Technologies Peer Group

Electromedical Technologies Ticker

OTC · EMEDOTC · EMED

Electromedical Technologies FIGI

EMED:US · BBG00PGH42V6EMED:PQ · BBG00PGH4380EMED:UV · BBG00PGH4399